300138 晨光生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)9.4302.85914.46014.58914.497
总资产报酬率 ROA (%)3.5781.0716.2056.7406.626
投入资产回报率 ROIC (%)3.8361.1446.6327.1787.001

边际利润分析
销售毛利率 (%)14.4817.96211.61213.94114.755
营业利润率 (%)7.3051.5167.9807.7357.897
息税前利润/营业总收入 (%)8.1402.5628.7788.3319.210
净利润/营业总收入 (%)6.1681.1157.1926.9277.194

收益指标分析
经营活动净收益/利润总额(%)88.888117.95675.69091.13987.395
价值变动净收益/利润总额(%)9.75011.85313.3166.6677.771
营业外收支净额/利润总额(%)0.4460.8511.3482.9393.315

偿债能力分析
流动比率 (X)1.3871.4811.6111.7871.483
速动比率 (X)0.9370.6410.8021.0490.652
资产负债率 (%)57.44865.03558.63753.57953.261
带息债务/全部投入资本 (%)52.16860.69654.31248.14847.292
股东权益/带息债务 (%)86.27260.77279.749101.822104.453
股东权益/负债合计 (%)72.91852.99269.30885.31387.821
利息保障倍数 (X)10.1452.48012.73723.0638.838

营运能力分析
应收账款周转天数 (天)24.44723.48920.08719.92325.436
存货周转天数 (天)179.426197.437155.053141.589174.224